Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
18.82
-0.47 (-2.41%)
Mar 31, 2025, 9:47 AM EDT - Market open
Tandem Diabetes Care Revenue
In the year 2024, Tandem Diabetes Care had annual revenue of $940.20M with 25.74% growth. Tandem Diabetes Care had revenue of $282.65M in the quarter ending December 31, 2024, with 43.62% growth.
Revenue (ttm)
$940.20M
Revenue Growth
+25.74%
P/S Ratio
1.34
Revenue / Employee
$354,794
Employees
2,650
Market Cap
1.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 940.20M | 192.49M | 25.74% |
Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
Dec 31, 2020 | 498.83M | 136.53M | 37.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TNDM News
- 11 days ago - Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes - Business Wire
- 12 days ago - Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States - Business Wire
- 4 weeks ago - Tandem Diabetes Q4 Earnings Review: I Don't Share The Market's Skepticism - Seeking Alpha
- 4 weeks ago - Tandem Diabetes Care, Inc. (TNDM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance - Business Wire
- 4 weeks ago - Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes - Business Wire
- 6 weeks ago - Tandem Diabetes Care Announces Upcoming Conference Presentations - Business Wire
- 2 months ago - Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Business Wire